Bypassing bypass surgery / by Cranton, Elmer M., author 537986

Subjects:

Litarge (Murdar Singh) Ingestion Induced Lead Toxicity: A Case Report. by Yeganeh Ramezani, Leila Etemad, Mohammad Moshiri

Subjects: Get full text

Osteosarcoma in Children: Not Only Chemotherapy by Maura Argenziano, Chiara Tortora, Elvira Pota, Alessandra Di Paola, Martina Di Martino, Caterina Di Leva, Daniela Di Pinto, Francesca Rossi

Subjects: Get full text

The impact of chelation compliance in health outcome and health related quality of life in thalassaemia patients: a systematic review by Wan Jin Lee, Nurul Ain Mohd Tahir, Geok Ying Chun, Shu Chuen Li

Subjects: Get full text

Iron chelating agents for iron overload diseases by Guido Crisponi, Valeria Marina Nurchi, Maria Antonietta Zoroddu

“…Although iron is an essential element for life, an excessive amount may become extremely toxic both for its ability to generate reactive oxygen species, and for the lack in humans of regulatory mechanisms for iron excretion. Chelation therapy has been introduced in clinical practice in the seventies of last century to defend thalassemic patients from the effects of iron overload and, in spite of all its limitations, it has dramatically changed both life expectancy and quality of life of patients. …”
Get full text

Deferasirox, an oral chelator in the treatment of iron overload by I. Portioli

“…BACKGROUND Deferasirox is a once-daily oral iron chelator developed for treating iron overload complicating long-term transfusion therapy in patients with diseases such as beta-thalassemia and myelodysplastic syndromes. …”
Get full text

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment/ by 495889 Byrne, A. T., O'Connor, AE, Hall, M, Murtagh, J, O'Neill, K, Curran, K. M., Mongrain, K, Rousseau, JA, Lecomte, R, McGee, S, Callanan, J. J., O'Shea, D. F., Gallagher, WM

P1511: EFFICACY AND SAFETY OF COMBINATION IRON CHELATION THERAPY WITH DEFERIPRONE AND DEFERASIROX IN PATIENTS WITH Β-THALASSEMIA MAJOR: A SYSTEMATIC LITERATURE REVIEW by A. Piga, S. Sheth, A. Kattamis, F. Tricta, E. Igboekwe, C. Fradette, J. Kwiatkowski

Get full text

Liver Dysfunction with Severe Cholestasis and Coagulation Disorders in the Course of Hemolytic Disease of the Newborn Requiring Chelation Therapy—A Case Report and Review of the Literature by Agnieszka Drozdowska-Szymczak, Julia Proczka, Danuta Chrzanowska-Liszewska, Krzysztof Truszkowski, Natalia Mazanowska, Paweł Krajewski

Subjects: Get full text

Site-Specific Dual-Labeling of a VHH with a Chelator and a Photosensitizer for Nuclear Imaging and Targeted Photodynamic Therapy of EGFR-Positive Tumors by Emma Renard, Estel Collado Camps, Coline Canovas, Annemarie Kip, Martin Gotthardt, Mark Rijpkema, Franck Denat, Victor Goncalves, Sanne A. M. van Lith

“…Here, we optimized site-specific conjugation of the chelator DTPA and the photosensitizer IRDye700DX to anti-epidermal growth factor receptor (EGFR) VHH 7D12, for applications in nuclear imaging and photodynamic therapy. 7D12 was site-specifically equipped with bimodal probe DTPA-tetrazine-IRDye700DX using the dichlorotetrazine conjugation platform. …”
Get full text

Novel Iron-Chelating Prodrug Significantly Enhanced Fluorescence-Mediated Detection of Glioma Cells Experimentally In Vitro by Charlotte Reburn, George Gawthorpe, Alexis Perry, Mark Wood, Alison Curnow

Subjects: Get full text

The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases by George J. Kontoghiorghes

Subjects: Get full text

Thalassemia and Nanotheragnostics: Advanced Approaches for Diagnosis and Treatment by Zahra Tariq, Muhammad Imran Qadeer, Iram Anjum, Christophe Hano, Sumaira Anjum

Subjects: Get full text

Home isolation in transfusion-dependent thalassemia patients with SARS CoV2 infection: Experience from a developing country by Shruti Kakkar, Vaneet Anand, Rashmi Kapoor, Sukhmani Sidhu, Amanat Grewal, Mehak Chawla, J.S. Goraya

Subjects: Get full text

Frequency of Glomerular Dysfunction in Children with Beta Thalassaemia Major by Basma A. Ali, Ahmed M. Mahmoud

Subjects: Get full text

“Heavy Metal”: Management of lead toxicity following a gunshot injury with retained lead fragments, a case report by Ilaria Costantini, Massimo Carollo, Lorenzo Losso, Elia Morando, Matilde Bacchion, Giovanni Mantelli, Mauro Pizzuto, Letizia Spagnuolo, Maria Vittoria Ventura, Giorgio Ricci

Subjects: Get full text

Dutch-beta thalassemia: A rare mutation from India by Nirali Sanghvi, Priyanka Aggarwal, Vineeta Singh, Vineeta Gupta

Subjects: Get full text

Novel Iron Chelator SK4 Drives Cytotoxicity through Inhibiting Mitochondrial Metabolism in Ovarian and Triple Negative Breast Cancer Cell Lines by Gina Abdelaal, Andrew Carter, William Cheung, Mihalis Panayiotidis, Seth Racey, David Tétard, Stephany Veuger

Subjects: Get full text

Approach to Occupational Cases of Lead Poisoning by Mohammad hosein Davari, Mojahede Salmani, Marjan Gharavi, Mojgan Piri Ardakani

Subjects: Get full text

Metabolic Analysis of DFO-Resistant Huh7 Cells and Identification of Targets for Combination Therapy by Koichi Fujisawa, Toshihiko Matsumoto, Naoki Yamamoto, Takahiro Yamasaki, Taro Takami

“…Since intracellular metabolism is significantly altered by inhibiting various proteins by iron chelation, we investigated combination anticancer therapy targeting metabolic changes that are forcibly modified by iron chelator administration. …”
Get full text